BASEL, Switzerland – 17th July 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer...
WOODSTOCK, Va., July 17, 2024 (GLOBE NEWSWIRE) -- Shenandoah Valley seniors and their families have something to celebrate: The Warren,...
- 6E10 combined with local prophylaxis selected for Phase 3 pivotal trials, with a favorable safety profile and potential best-in-class...
EssilorLuxottica signs an agreement to acquire a majority stake in Heidelberg Engineering and continues to make moves in the med-tech space...
EssilorLuxottica to Acquire Supreme® from VF Corporation Paris, France and Denver, CO (17 July 2024 – 8am CEST) - EssilorLuxottica,...
Company strengthens sustainability practices prior to commercializationEINDHOVEN, the Netherlands, July 17, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD),...
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION17 JULY 2024 at 8.30 EEST Inside information: Phase III ARANOTE...
After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%; p <...
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities...
BURLINGTON, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second...
In a release issued under the same headline on July 12, 2024 by Onco360 Oncology Pharmacy, please note the change...
ORIC-944, a potential best-in-class PRC2 inhibitor, is being evaluated in combination with darolutamide and in combination with apalutamide in patients...
FOSTER CITY, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical...
Subtle Medical's new software is now available for clinical use in the US, further redefining the speed and quality of...
PALO ALTO, CA / ACCESSWIRE / July 17, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is pleased...
VANCOUVER, BC / ACCESSWIRE / July 17, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...
MINNEAPOLIS, July 16, 2024 /PRNewswire/ -- MNGI Digestive Health ("MNGI") has learned of a data security incident that may have...